Marsha Rosner: Cannabidiol (CBD), Antiviral Drugs, SARS-CoV-2 & Cancer Biology | #59

1 Views

07/13/23

Nick Jikomes talks to cancer biologist Dr. Marsha Rosner, who is a Professor of Cancer Research at the University of Chicago. Her lab focuses largely on understanding the biochemical signaling mechanisms that lead to the generation of tumor cells, as well as how and why cancer cells metastasize, which is when they travel from one part of the body to another.

Nick and Dr. Rosner and discuss mainly a recent study she led about the antiviral effects of cannabidiol (CBD) against SARS-CoV-2, including: why a cancer lab was working with CBD to begin with; what the results of her study actually show in terms of CBD’s antiviral effects; whether other cannabinoids showed this effect. She also commented on some misconceptions that have been circulating regarding this work, and described some of the clinical trials her team is running to measure CBD’s potential as an anti-COVID drug.

USEFUL LINKS
Sign up for the weekly Mind & Matter newsletter
[https://mindandmatter.substack.com/?sort=top]

Download the podcast & follow Nick at his website
[https://www.nickjikomes.com]

Follow Nick's work through Linktree:
[https://linktr.ee/trikomes]

Athletic Greens, comprehensive daily nutrition (Free 1-year supply Vitamin D w/ purchase)
[https://www.athleticgreens.com/mindandmatter]

Organize your digital highlights & notes w/ Readwise (2 months free w/ sub)
[https://readwise.io/nickjikomes/]

Learn more about our podcast sponsor, Dosist
[https://dosist.com]

0:00:00 Episode Intro
0:03:23 Marsha Rosner Intro, CBD, Cellular Stress
0:13:25 What kind of CBD used in study?
0:20:54 Are Other Cannabinoids Antiviral?
0:30:37 How Does CBD Interfere With SARS-CoV-2?
0:50:55 Antiviral Effect in Rodents
0:53:39 COVID Rates in human Patients Taking CBD
1:11:24 Comparison to Other Studies & Human Clinical Trials
1:18:03 Cancer Biology & Metastasis
1:23:11 Final Thoughts